BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36069287)

  • 1. Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001-2017.
    McEvoy MT; Siegel DA; Dai S; Okcu MF; Zobeck M; Venkatramani R; Lupo PJ
    Cancer Med; 2023 Feb; 12(3):3644-3656. PubMed ID: 36069287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005.
    Ognjanovic S; Linabery AM; Charbonneau B; Ross JA
    Cancer; 2009 Sep; 115(18):4218-26. PubMed ID: 19536876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States.
    Kahla JA; Siegel DA; Dai S; Lupo PJ; Foster JH; Scheurer ME; Heczey AA
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29763. PubMed ID: 35591805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019.
    Campbell K; Siegel DA; Umaretiya PJ; Dai S; Heczey A; Lupo PJ; Schraw JM; Thompson TD; Scheurer ME; Foster JH
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30732. PubMed ID: 37867409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.
    Turner JH; Richmon JD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):967-73. PubMed ID: 21873599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric head and neck rhabdomyosarcoma: An analysis of treatment and survival in the United States (1975-2016).
    Darwish C; Shim T; Sparks AD; Chillakuru Y; Strum D; Benito DA; Monfared A
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110403. PubMed ID: 33049553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020.
    Arnett A; Siegel DA; Dai S; Thompson TD; Foster J; di Pierro EJ; Momin B; Lupo PJ; Heczey A
    medRxiv; 2024 Apr; ():. PubMed ID: 38633779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of pediatric middle ear tumors and analysis of the demographics, management, and survival of pediatric rhabdomyosarcomas of the middle ear.
    Janz TA; Camilon PR; Cheung AY; Nguyen SA; White DR; Weber PC
    Int J Pediatr Otorhinolaryngol; 2018 Sep; 112():109-112. PubMed ID: 30055718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and prognosis of embryonal rhabdomyosarcoma in children and adolescents: An analysis of 464 cases from the SEER database.
    Wang X; Feng J; Li Z; Zhang X; Chen J; Feng G
    Pediatr Investig; 2020 Dec; 4(4):242-249. PubMed ID: 33376951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcomes of infants compared with children diagnosed with rhabdomyosarcoma: Analysis of surveillance, epidemiology and end results data from 2000 to 2016.
    Rees HD; Hills NK; Sabnis AJ; Tulpule AB; Shimotake TK; Goldsby RE
    Cancer Rep (Hoboken); 2022 May; 5(5):e1503. PubMed ID: 34254742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, Incidence, and Survival of Rhabdomyosarcoma Subtypes: SEER and ICES Database Analysis.
    Amer KM; Thomson JE; Congiusta D; Dobitsch A; Chaudhry A; Li M; Chaudhry A; Bozzo A; Siracuse B; Aytekin MN; Ghert M; Beebe KS
    J Orthop Res; 2019 Oct; 37(10):2226-2230. PubMed ID: 31161653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.
    Lupo PJ; Danysh HE; Plon SE; Curtin K; Malkin D; Hettmer S; Hawkins DS; Skapek SX; Spector LG; Papworth K; Melin B; Erhardt EB; Grufferman S; Schiffman JD
    Cancer Med; 2015 May; 4(5):781-90. PubMed ID: 25809884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group.
    Martin-Giacalone BA; Richard MA; Scheurer ME; Khan J; Sok P; Shetty PB; Chanock SJ; Li SA; Yeager M; Marquez-Do DA; Barkauskas DA; Hall D; McEvoy MT; Brown AL; Sabo A; Scheet P; Huff CD; Skapek SX; Hawkins DS; Venkatramani R; Mirabello L; Lupo PJ
    J Natl Cancer Inst; 2023 Jun; 115(6):733-741. PubMed ID: 36951526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype.
    Ognjanovic S; Carozza SE; Chow EJ; Fox EE; Horel S; McLaughlin CC; Mueller BA; Puumala S; Reynolds P; Von Behren J; Spector L
    Br J Cancer; 2010 Jan; 102(1):227-31. PubMed ID: 19997102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyosarcoma in children: a SEER population based study.
    Perez EA; Kassira N; Cheung MC; Koniaris LG; Neville HL; Sola JE
    J Surg Res; 2011 Oct; 170(2):e243-51. PubMed ID: 21529833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 17. Population-based survival of pediatric rhabdomyosarcoma of the head and neck over four decades.
    Curry SD; Jiang ZY; Jain KS
    Int J Pediatr Otorhinolaryngol; 2021 Mar; 142():110599. PubMed ID: 33422992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic traits and prognostic factors associated with pediatric sinonasal rhabdomyosarcoma.
    Siddiqui SH; Siddiqui E; Bavier RD; Patel NM; KiliƧ S; Baredes S; Hsueh WD; Eloy JA
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):363-369. PubMed ID: 30629809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram.
    De Salvo GL; Del Bianco P; Minard-Colin V; Chisholm J; Jenney M; Guillen G; Devalck C; Van Rijn R; Shipley J; Orbach D; Kelsey A; Rogers T; Guerin F; Scarzello G; Ferrari A; Cesen Mazic M; Merks JHM; Bisogno G;
    Cancer; 2024 Feb; ():. PubMed ID: 38400828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.